Safety and tolerance of dietary supplementation with a canine-derived probiotic (bifidobacterium animalis strain AHC7) fed to growing dogs

Veterinary Therapeutics

Volumn 11, Issue 3, 2010, Pages

  Kelley, R L ^a   Park, Jean Soon ^a   O'Mahony, Liam ^b,c   Minikhiem, Debbie ^a   Fix, Andrew ^a  

^a PROCTER AND GAMBLE COMPANY   (United States)

^b ALIMENTARY HEALTH LTD   (Ireland)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; BIFIDOBACTERIUM ANIMALIS; CANIS FAMILIARIS;

EID: 77958584040     PISSN: 15283593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Schrezenmeir J, de Vrese M. Probiotics, prebiotics, and synbiotics-approaching a definition. Am J Clin Nutr 2001;73(suppl):361S-364S.
2. Weese JS. Evaluation of deficiencies in labeling of commercial probiotics. Can Vet J 2003;44:982-983
3. Boyle RJ, Robins-Browne RM, Tang MLK. Probiot- ic use in clinical practice: what are the risks? Am J Clin Nutr 2006;83:1256-1264.
4. Hammerman C, Bin-Nun A, Kaplan M. Safety of probiotics: comparison of two popular strains. BMJ 2006;333:1006-1008.
5. Ishibashi N, Yamazaki S. Probiotics and safety. Am J Clin Nutr 2001;73(suppl):465S-470S.
6. Vlieger AM, Robroch A, van Buuren S, et al. Toler- ance and safety of Lactobacillus paracasei ssp. Paracasei in combination with Bifidobacterium animalis ssp. lactis in a prebiotic-containing infant formula: a ran- domized controlled trial. Br J Nutr 2009;102:869-875.
7. Vogel G. Deaths prompt a review of experimental probiotic therapy. Science 2008;319:557.
8. O'Mahony D, Murphy KB, MacSharry J, et al. Portrait of a canine probiotic Bifidobacterium-from gut to gut. Vet Microbiol 2009;139:106-112.
9. Kelley RL, Minikhiem D, Kiely B, et al. Clinical benefits of probiotic canine-derived Bifidobacterium ani- malis strain AHC7 in dogs with acute idiopathic diar- rhea. Vet Ther 2009;10:121-130.
10. Sakata S, Kitahara M, Sakamoto M, et al. Unification of Bifidobacterium infantis and Bifidobacterium suis as Bifidobacterium longum. Int J Syst Evol Microbiol 2002;52:1945-1951.
11. Mayer HK, Amtmann E, Philippi E, et al. Molecular discrimination of new isolates of Bifidobacterium ani- malis subsp. lactis from reference strains and commer- cial probiotic strains. Int Dairy J 2007;17:565-573.
12. Willard MD, Twedt DC. Gastrointestinal, pancreatic, and hepatic disorders. In: Willard MD, Tvedten H, eds. Small Animal Clinical Diagnosis by Laboratory Methods. 4th ed. St. Louis: Saunders; 2004:208-246.
13. The hematopoietic and lymphoid systems. In: Hoskins JD. Veterinary Pediatrics: Dogs and Cats from Birth to Six Months. 3rd ed. Philadelphia: WB Saun- ders; 2001:300-343.
14. DiBartola SP, Green RA, de Morais HSA, Willard MD. Electrolyte and acid-base disorders. In: Willard MD, Tvedten H, Turnwald GH, eds. Small Animal Clinical Diagnosis by Laboratory Methods. 3rd ed. Philadelphia: Saunders; 1999:93-108.
15. Gilman J, Cashman KD. The effect of probiotic bacteria on transepithelial calcium transport and calcium uptake in human intestinal-like Caco-2 cells. Curr Is- sues Intest Microbiol 2006;7(1):1-5.
16. Borthakur A, Gill RK, Tyagi S, et al. The probiotic Lactobacillus acidophilus stimulates chloride/hydroxyl exchange activity in human intestinal epithelial cells. J Nutr 2008;138(7):1355-1359.
17. Procter & Gamble Pet Care, Lewisburg, OH. Unpublished data.